Stockreport

Tenaya Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]

Tenaya Therapeutics, Inc.  (TNYA) 
PDF Tenaya Therapeutics, Inc. Reported Promising Data for TN-201 and TN-401 Gene Therapies in Fourth Quarter of 2025; Additional Data Readouts and Pursuit of Regulatory A [Read more]